The Future of Cancer Treatment: Using Immunotherapy for Advanced Prostate Cancer
Summary
- Discover how partial ablation, rather than full tumor removal, can stimulate immune responses against prostate cancer
- Learn about SynkroT, a new immunotherapy with promising results in early clinical trials for metastatic prostate cancer
- Understand the future potential of combining immunotherapy with focal treatments for a systemic impact on advanced cancers
- This video is part of the Prostate Cancer Summit 2.0
